Amberlite IRC-718 ion chelating resin extraction of hazardous metal Cr (VI) from aqueous solutions: equilibrium and theoretical modeling.

Under varied conditions, the IRC 718 ion-exchange resin is used to extract chromium (VI) ions from aqueous solutions. On chromium (VI) removal effectiveness, the effects of adsorption dosage, contact time, beginning metal concentration, and pH were examined. The batch ion exchange process reached equilibrium after around 90 minutes of interaction.

Development of prohibitin ligands against osteoporosis.

Current therapeutic approaches to osteoporosis display some potential adverse effects and a limited efficacy on non-vertebral fracture reduction. Some sulfonylamidines targeting the scaffold proteins prohibitins-1 and 2 (PHB1/2) have been showed to inhibit the formation of osteoclasts in charge of bone resorption. Herein, we report the development of a second generation of anti-osteoclastic PHB ligands.

Benzimidazolium- and Benzimidazolilydene-Capped Cyclodextrins: New Perspectives in Anion Encapsulation and Gold-Catalyzed Cycloisomerization of 1,6-Enynes.

A new way of introducing a N-heterocyclic carbene cap onto cyclodextrins has been devised. The benzimidazolium intermediates were found to behave as receptors towards cavity matching anions. The corresponding C - and C -symmetrical regioisomeric carbene gold(I) complexes have been tested in a benchmark asymmetric cycloisomerization of 1,6-enynes.

Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.

Prohibitins 1 and 2 (PHB1/2) are scaffold proteins that are involved in both melanogenesis and oncogenic pathways. We hypothesized that a PHB1 ligand, melanogenin, may display anti-cancer effects in addition to its known melanogenic activity in melanocytes. Here, we disclose a convenient synthesis of melanogenin, and its analogs.

Formation of Mono- and Polynuclear Luminescent Lanthanide Complexes based on the Coordination of Preorganized Phosphonated Pyridines.

A series of polynuclear assemblies based on ligand L (1,4,7-tris[hydrogen (6-methylpyridin-2-yl)phosphonate]-1,4,7-triazacyclononane) has been developed. The coordination properties of ligand L with Ln (Ln = La, Eu, Tb, Yb, Lu) have been studied in water (pH = 7.0) and in DO (pD = 7.

Cancer wars: natural products strike back.

Natural products have historically been a mainstay source of anticancer drugs, but in the 90's they fell out of favor in pharmaceutical companies with the emergence of targeted therapies, which rely on antibodies or small synthetic molecules identified by high throughput screening. Although targeted therapies greatly improved the treatment of a few cancers, the benefit has remained disappointing for many solid tumors, which revitalized the interest in natural products. With the approval of rapamycin in 2007, 12 novel natural product derivatives have been brought to market.

A comparison of the acidity and the complexing ability of (o-hydroxyphenyl) bis- and (o-hydroxyphenyl) mono-methylenephosphonic acids towards lanthanide(III) ions.

The characterization of the acid-base properties of a family of three phenoldimethylenephosphonic acids differently substituted by auxo- or chromophoric groups was studied. These ligands may be considered as pentaacids. Their pK(a) were determined in aqueous solution at 25 degrees C and constant ionic strength 0.